Browsing Tag
Zejula
3 posts
GSK India delivers 32% profit surge—Zejula and Jemperli launches set to transform cancer care
GSK India reports 32% PAT growth in FY25; read how oncology launches and vaccine growth are shaping the company’s future outlook.
GSK announces significant survival results for Jemperli in endometrial cancer trial
In a significant development for patients with primary advanced or recurrent endometrial cancer, GSK plc (LSE/NYSE: GSK) has…
GSK completes $5.1bn acquisition of Tesaro to boost oncology pipeline
GlaxoSmithKline (GSK), the British pharmaceutical powerhouse, has successfully concluded its $5.1 billion acquisition of Tesaro, a leading oncology-focused…